Why do we have Speaker Compliance Guidelines and Training?

Size: px
Start display at page:

Download "Why do we have Speaker Compliance Guidelines and Training?"

Transcription

1

2 Disclaimer The views expressed in this presentation are the views of the facilitators and do not necessarily represent the views or policies of our employer.

3

4

5 Why do we have Speaker Compliance Guidelines and Training? Pharmaceutical companies are responsible for activities conducted by or on behalf of that Company Considerations when engaging Speakers/Consultants: Speakers are acting on behalf of your Company Speakers are held to the same regulatory standards as your Company employees Speakers should only use your Company approved slide deck and materials Speakers should have fully executed contract in place with your Company 5

6

7 FDA Monitoring The FDA monitors company controlled activities by the pharmaceutical industry, examples include: Including complaints from speaker program attendees regarding inappropriate activities FDA s Bad Ad Program The FDA has cited companies and speakers for violations made by their speakers Such letters are made public on the FDA website

8 The Compliance Environment Compliance policies are based on government laws, regulations, industry codes and company guidelines Non-compliance can result in: Industry Fines Corporate Integrity Agreements (CIA) Government exclusion from federal health care programs (Medicare and Medicaid)

9

10 Criteria, criteria, criteria What does the selection process look like within your company? Where do speaker recommendations originate? How has Open Payments impacted speaker availability? Expected qualifications well documented? National/Regional/Local designations? Minimum requirements for continued participation?

11 Example Selection Process Criteria National Faculty Criteria Tier 1 Tier 2 Tier 3 Primary Considerations: -Years since Post Graduate Completion Professional Organizations (medically related) Presentations (includes promo, grand rounds, CME, etc.) Publications (includes articles & abstracts) Research experiences/trials Yes Yes No Optional Considerations: -Academic Appointments Yes Yes No -Previous Speaker Bureau experience (any company) Yes Yes No Minimum # of Qualifications Met: Minimum Primary Criteria Met

12

13 Speaker training, what does it look like? Who in your company is responsible for designing, creating and executing Speaker Training? Is there a standardized process? How is it executed? Live, virtual, other? How are you addressing scenarios where speakers cannot attend training? How are they trained to handle: Unsolicited off-label questions? Questions regarding reimbursement? Reports of Adverse Events or Product Quality Complaints? How do you handle speaker requests to modify or add slides? Speaker provides an additional handout to the audience, not company approved

14 Purpose of Programs GOAL Provide Truthful, Balanced and Accurate information about our company products to Health Care Professionals and Patients Promotional speakers : Remain on-label Provide information that is truthful and not false/misleading Provide fair-balance with product risk/benefit Only use the slide deck approved and provided by the Company Not solicit off-label inquiries

15 What is Considered Off-Label? Information not consistent with the FDA-approved PI is considered off-label Although physicians may prescribe or use products for off-label uses, the FDA currently prohibits pharmaceutical companies, and consequently any employees or representatives engaged in selling or marketing the Company's products, to promote those unapproved, or off-label uses

16 Program Watch Outs Promotional Speakers : Proactively discuss off-label use of the product Broaden of product indication Present data out of context Minimize safety issues Omit material information Compare efficacy or safety claims without substantial evidence Overstate efficacy or safety

17

18 Employee Training Beyond the standard HCC training, does your company conduct additional training for employees regarding Speaker Programs? What resources or tools do you make available? Does on-the-job training come into play? If so, is it standardized?

19

20 Summary: Company Representatives Provide attendees with Package Insert or company approved materials with Package Insert Should not interject while speaker is presenting approved content or solicit speaker to discuss off-label information Address speaker should he or she solicit discussions on off-label information Complete the speaker evaluation Report any non-compliance to manager and Health Care Compliance Officer immediately.

21

22 Mitigating Risks What safeguards do you have established regarding compliant speaker programs? Observations what is your process? How are observations allocated? Risk based?? Who conducts observations? How are they trained? Process for scheduling? Heads up vs. show up? Third-Party Vendor what is the scope of their role in this process? Other ways to mitigate risk?

23

WALKING THE COMPLIANCE LINE: A REGULATORY LAWYER S PERSPECTIVE

WALKING THE COMPLIANCE LINE: A REGULATORY LAWYER S PERSPECTIVE WALKING THE COMPLIANCE LINE: A REGULATORY LAWYER S PERSPECTIVE Presented By: Alan B. Minsk Partner and Chair, Food and Drug Practice Team Arnall Golden Gregory LLP alan.minsk@agg.com Presented To: ISMPP

More information

Business Conduct Standards for Interactions with Healthcare Professionals. Pocket Guide for U.S. Sales Professionals. Do The Right Thing

Business Conduct Standards for Interactions with Healthcare Professionals. Pocket Guide for U.S. Sales Professionals. Do The Right Thing Business Conduct Standards for Interactions with Healthcare Professionals Pocket Guide for U.S. Sales Professionals Do The Right Thing As Amgen s Vice President of Sales and Marketing Operations and Planning,

More information

Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402

Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402 Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402 I. INTRODUCTION Bayer HealthCare LLC [including Bayer HealthCare LLC Dermatology Division

More information

U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT

U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT Effective: January 1, 2009 U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT January 1, 2009 I. INTRODUCTION Table of Contents II. COMPLIANCE

More information

Code of Conduct. Compliance W.I.N.S Worldwide Integrity is Necessary for Success

Code of Conduct. Compliance W.I.N.S Worldwide Integrity is Necessary for Success Code of Conduct Compliance W.I.N.S Worldwide Integrity is Necessary for Success Effective February 2014 Disclaimer BEFORE YOU BEGIN You are being provided this certification to assist you in meeting your

More information

Amgen GLOBAL CORPORATE COMPLIANCE POLICY

Amgen GLOBAL CORPORATE COMPLIANCE POLICY 1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,

More information

Keeping our Focus: Compliance Summary for Customers and Health Care Professionals. Understanding the Olympus Health Care Compliance Code of Conduct

Keeping our Focus: Compliance Summary for Customers and Health Care Professionals. Understanding the Olympus Health Care Compliance Code of Conduct Keeping our Focus: Compliance Summary for Customers and Health Care Professionals Understanding the Olympus Health Care Compliance Code of Conduct Introduction Olympus Corporation of the Americas ( Olympus

More information

DUVAL CLIENT ALERT December 2009

DUVAL CLIENT ALERT December 2009 1 P a g e DUVAL CLIENT ALERT December 2009 In this DUVAL CLIENT ALERT, we list practical ways medical device companies can lawfully communicate about their products prior to FDA clearance or approval.

More information

Orange Guide (also known as the Field Guide)

Orange Guide (also known as the Field Guide) Pfizer Inc 235 East 42nd Street New York, NY 10017 www.pfizer.com Dear Colleagues: At Pfizer, we are committed to upholding the highest standards when we interact with physicians, healthcare organizations,

More information

Use of Social Media by Pharmaceutical Medical Information Teams

Use of Social Media by Pharmaceutical Medical Information Teams www.arisglobal.com A White Paper Presented By ArisGlobal Use of Social Media by Pharmaceutical Medical Information Teams Ome Ogbru, PharmD, Medical Information SME What is Social Media? The Merriam-Webster

More information

Introduction to Compliance with FDA Labeling and Advertising Requirements

Introduction to Compliance with FDA Labeling and Advertising Requirements Introduction to Compliance with FDA Labeling and Advertising Requirements Second Annual Pharmaceutical Industry Regulatory and Compliance Summit Dick Kenny FDA History Basic function of government Oldest

More information

A PASSION FOR INTEGRITY. Every Day Health Care Compliance. Code of Conduct

A PASSION FOR INTEGRITY. Every Day Health Care Compliance. Code of Conduct A PASSION FOR INTEGRITY Every Day Health Care Compliance Code of Conduct Health Care Compliance Is Everyone s Responsibility Johnson & Johnson Pharmaceutical Affiliates are known the world over for innovative,

More information

1 st Tier & Downstream Training Focus

1 st Tier & Downstream Training Focus Colorado Access Advantage (HMO) Medicare Advantage Part D Fraud, Waste and Abuse Compliance Training 2010 Introduction 2 The Centers for Medicare & Medicaid Services (CMS) requires annual fraud, waste

More information

Physicians Expectations of Industry and Sales Personnel

Physicians Expectations of Industry and Sales Personnel American Medical Association What You Should Know About Gifts to Physicians from Industry MODULE 2: Physicians Expectations of Industry and Sales Personnel Author: Janet Lucy Rose, PA-C, MBA An American

More information

Fraud, Waste and Abuse Training

Fraud, Waste and Abuse Training Fraud, Waste and Abuse Training 1 Why Do I Need Training? Every year millions of dollars are improperly spent because of fraud, waste and abuse. It affects everyone, Including YOU. This training will help

More information

University of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents

University of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents University of Central Florida College of Medicine Industry Relations Policy and Guidelines 1. Introduction and Scope of Policy 2. Statement of Policy Table of Contents 3. Gifts and Individual Financial

More information

CORPORATE INTEGRITY AGREEMENT

CORPORATE INTEGRITY AGREEMENT CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND GLAXOSMITHKLINE LLC I. PREAMBLE (GSK) hereby enters into this Corporate Integrity

More information

LIBRARY GUIDE: Medical Device Sales & Marketing

LIBRARY GUIDE: Medical Device Sales & Marketing LIBRARY GUIDE: Medical Device Sales & Marketing Page 2 Table of Contents Overview... 2 About Our Health Care Compliance Solution... 2 Our Relationship With AdvaMed... 2 Course Descriptions: Basics of the

More information

Can You Get Insurance Coverage for False Claims Act and Similar Claims? Making Sure You ve Looked at All Possible Avenues of Recovery

Can You Get Insurance Coverage for False Claims Act and Similar Claims? Making Sure You ve Looked at All Possible Avenues of Recovery Can You Get Insurance Coverage for False Claims Act and Similar Claims? Making Sure You ve Looked at All Possible Avenues of Recovery Presented by Brennan Torregrossa Asst. General Counsel Dispute Resolution

More information

PhRMA Code on Interactions with Healthcare Professionals

PhRMA Code on Interactions with Healthcare Professionals PhRMA Code on Interactions with Healthcare Professionals Preamble The Pharmaceutical Research and Manufacturers of America (PhRA4.A) represents research-basedpharmaceutical and biotechnology companies.

More information

3. HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION

3. HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION 1. PURPOSE It is the goal of UCB, Inc. (UCB) to ensure that its marketing and promotional activities comply with all applicable state and federal laws. In addition, UCB Inc. endeavors to conform to pertinent

More information

Meeting the HIPAA Training and Business Associate Requirements Questions and Answers, with HIPAA Security Expert Mike Semel

Meeting the HIPAA Training and Business Associate Requirements Questions and Answers, with HIPAA Security Expert Mike Semel Meeting the HIPAA Training and Business Associate Requirements Questions and Answers, with HIPAA Security Expert Mike Semel Questions Answers 1 Is a Business Associate (BA) responsible for assuming a Covered

More information

Is it time for a new drug development paradigm?

Is it time for a new drug development paradigm? Is it time for a new drug development paradigm? Robert McDonough, M.D. Senior Director, Clinical Policy Research and Development 1 The Aetna Way Our Cause To make quality health care more affordable and

More information

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010 Medicare Advantage and Part D Fraud, Waste, and Abuse Training October 2010 Introduction 2008: United States spent $2.3 trillion on health care. Federal fiscal year 2010: Medicare expected to cover an

More information

Fraud Waste and Abuse Training Requirement. To Whom It May Concern:

Fraud Waste and Abuse Training Requirement. To Whom It May Concern: RE: Fraud Waste and Abuse Training Requirement To Whom It May Concern: This letter is to inform you about a new requirement being implemented by the CMS program (Centers for Medicare and Medicaid Services)

More information

The Chairman s Message on Health Care Compliance

The Chairman s Message on Health Care Compliance 904438_JnJ_EmpGde 9/17/09 8:37 AM Page FC2 The Chairman s Message on Health Care Compliance Johnson & Johnson is known the world over for innovative, life-saving medical products and for the values we

More information

CORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS

CORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS CORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS This Second Amended and Restated Code of Business Conduct and Ethics (the Code ) sets forth legal and ethical

More information

Upcoming OCR Audits for HIPAA Compliance: How Prepared and Confident are Medical Practices and Billing Companies?

Upcoming OCR Audits for HIPAA Compliance: How Prepared and Confident are Medical Practices and Billing Companies? Upcoming : How Prepared and Confident are Medical Practices and Billing Companies? - Presented by NueMD a complete medical billing and practice management software solution company has partnered with Porter

More information

International Transplant Nurses Society Speaker / Planner Bio Form

International Transplant Nurses Society Speaker / Planner Bio Form Ohio Nurses Association Biographical Data Form (2009 Criteria) Instructions: If you are a planner for this activity, complete Sections 1, 2, 4, 5 & 7. If you are a speaker/ content expert for this activity,

More information

Orange Guide (also known as the Field Guide)

Orange Guide (also known as the Field Guide) Pfizer Inc 235 East 42nd Street New York, NY 10017 www.pfizer.com Dear Colleagues: At Pfizer, we are committed to upholding the highest standards when we interact with physicians, healthcare organizations,

More information

Mitigating Compliance

Mitigating Compliance 6 Baltzer Science Publishers Mitigating Compliance Risks Across The Sales Execution Cycle Wendy Heckelman* U.S. Government regulators are focusing on a wider range of sales practices in their investigations

More information

Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy. Introduction

Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy. Introduction Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy Introduction The faculty 1 and medical students of the Joan C. Edwards School of Medicine (SOM) have responsibilities

More information

Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training

Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training Overview This Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training for first-tier, downstream and related entities

More information

Understanding the Key Challenges when Entering into a Corporate Integrity Agreement

Understanding the Key Challenges when Entering into a Corporate Integrity Agreement Understanding the Key Challenges when Entering into a Corporate Integrity Agreement Understanding the Key Challenges when Entering into a Corporate Integrity Agreement Not long ago, Corporate Integrity

More information

University of Miami Miller School of Medicine

University of Miami Miller School of Medicine University of Miami Miller School of Medicine Policy UMMG [University of Miami Medical Group] Policy: Pharmaceutical/Device Representative Interaction Division of Continuing Medical Education Website Date

More information

INTEGRITY IN ACTION - HEALTH CARE COMPLIANCE

INTEGRITY IN ACTION - HEALTH CARE COMPLIANCE A PASSION FOR INTEGRITY INTEGRITY IN ACTION - HEALTH CARE COMPLIANCE HEALTH CARE COMPLIANCE IS EVERYONE S RESPONSIBILITY DePuy Synthes is known the world over for innovative, life enhancing orthopedic

More information

LIBRARY GUIDE: Pharmaceutical Sales & Marketing

LIBRARY GUIDE: Pharmaceutical Sales & Marketing LIBRARY GUIDE: Pharmaceutical Sales & Marketing Page 2 Pharmaceutical Sales and Marketing Course Library Table of Contents: Courses Listed by Functional Area... 4 Basics of the PhRMA Code (PHSM01)...5

More information

Regulatory Affairs Professionals Society: Regulatory Affairs Certification (RAC) Study Group FDA Regulation of Advertising and Promotion

Regulatory Affairs Professionals Society: Regulatory Affairs Certification (RAC) Study Group FDA Regulation of Advertising and Promotion Regulatory Affairs Professionals Society: Regulatory Affairs Certification (RAC) Study Group FDA Regulation of Advertising and Promotion Alex Toy July 14, 2013 1 Agenda FDA Regulatory Framework Office

More information

The Ohio State University Medical Center Vendor Interaction Policy Approved OSUMC Executive Cabinet, March 12, 2009 Policy effective July 1, 2009

The Ohio State University Medical Center Vendor Interaction Policy Approved OSUMC Executive Cabinet, March 12, 2009 Policy effective July 1, 2009 The Ohio State University Medical Center Vendor Interaction Policy Approved OSUMC Executive Cabinet, March 12, 2009 Policy effective July 1, 2009 Purpose All healthcare professionals and institutions have

More information

CME Updates Douglas W. Hanto, M.D., PhD Associate Dean for Continuing Medical Education Professor of Surgery

CME Updates Douglas W. Hanto, M.D., PhD Associate Dean for Continuing Medical Education Professor of Surgery CME Updates Douglas W. Hanto, M.D., PhD Associate Dean for Continuing Medical Education Professor of Surgery Vicki Tegethoff, RN, MHA Director of CME cme.wustl.edu Purpose of this Presentation This presentation

More information

MA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations

MA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations MA Healthcare Reform Legislation: Overview of Massachusetts Department of Public Health Regulations Melissa J. Lopes, Deputy General Counsel Massachusetts Department of Public Health Marissa Seligman,

More information

RE: NDA: 021876 DICLEGIS (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets, for oral use MA # 350 WARNING LETTER

RE: NDA: 021876 DICLEGIS (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets, for oral use MA # 350 WARNING LETTER DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 TRANSMITTED BY FACSIMILE Eric Gervais, Executive Vice President 919 Conestoga Road Building

More information

02/2013. Editorial. Mitigating Compliance Risks. Piergiorgio Pepe Antitrust Compliance: The Benefits and Impact

02/2013. Editorial. Mitigating Compliance Risks. Piergiorgio Pepe Antitrust Compliance: The Benefits and Impact LIFE SCIENCE COMPLIANCE 02/2013 EDITOR-IN-CHIEF: SUE EGAN Editorial Wendy Heckelman Mitigating Compliance Risks Across The Sales Execution Cycle Brigette Wilds Are you talking to me? Making compliance

More information

Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices

Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices DRAFT GUIDANCE This guidance document is being distributed for comment purposes

More information

POLICY AND PROCEDURES OFFICE OF EXECUTIVE PROGRAMS. Accreditation -- Continuing Education. Table of Contents

POLICY AND PROCEDURES OFFICE OF EXECUTIVE PROGRAMS. Accreditation -- Continuing Education. Table of Contents POLICY AND PROCEDURES OFFICE OF EXECUTIVE PROGRAMS Accreditation -- Continuing Education Table of Contents PURPOSE...1 BACKGROUND...1 POLICY...3 RESPONSIBILITIES...7 PROCEDURES...7 REFERENCES...8 DEFINITIONS...8

More information

Advertising Compliance Questions and Answers by David Dickinson

Advertising Compliance Questions and Answers by David Dickinson Advertising Compliance Questions and Answers by David Dickinson This publication is not offered as legal advice. Readers should consult with legal counsel on specific fact situations. What Is An Advertisement?

More information

HIPAA Privacy Rule Policies

HIPAA Privacy Rule Policies DRAFT - Policies and Procedures PRIVACY OFFICE ASSIGNMENT AND RESPONSIBILITIES APPROVED BY: SUPERCEDES POLICY: Policy #1 ADOPTED: REVISED: REVIEWED: Purpose This policy is designed to assure the establishment

More information

Law Summer School (LSS) Bangalore

Law Summer School (LSS) Bangalore Disclaimer: This is a translation of the original document in German. It is provided for information purposes only and has no legal bearing. Faculty of Law Program Regulations Law Summer School (LSS) Bangalore

More information

CMS Mandated Training for Providers, First Tier, Downstream and Related Entities

CMS Mandated Training for Providers, First Tier, Downstream and Related Entities CMS Mandated Training for Providers, First Tier, Downstream and Related Entities I. INTRODUCTION It is the practice of Midwest Health Plan (MHP) to conduct its business with the highest degree of ethics

More information

COMPLIANCE Solutions. Risky Business? Haunting Prose. 2012 In The Line Of Fire. Responsible Executive MEDICAL DEVICE BUTLER SNOW.

COMPLIANCE Solutions. Risky Business? Haunting Prose. 2012 In The Line Of Fire. Responsible Executive MEDICAL DEVICE BUTLER SNOW. MEDICAL DEVICE COMPLIANCE Solutions Spring, 2012 BUTLER SNOW Haunting Prose Ghostwriting and Transparency in Pharmaceutical and Medical Device Publications Risky Business? Assessing Risks with A Risk Assessment

More information

Standards for Programs Designated for AAPA Category 1 CME Credit

Standards for Programs Designated for AAPA Category 1 CME Credit Standards for Programs Designated for AAPA Category 1 CME Credit CME Mission Statement The mission of the AAPA s CME Review Panel is to review and approve appropriate clinical and professional educational

More information

Board Statute Regarding Gifts to Physicians

Board Statute Regarding Gifts to Physicians Board Statute Regarding Gifts to Physicians KRS 311.595(9), as illustrated by KRS 311.597(4), provides that it is a statutory violation, and a basis for disciplinary action against a license, for a licensed

More information

1.3 There have been no material or substantive changes to the Code since last year.

1.3 There have been no material or substantive changes to the Code since last year. 1. Please describe the key components of the GPO s written code of business ethics and conduct. (Please provide a copy and describe any changes since the last submission.) Please assure your response includes:

More information

SUPPLEMENTAL NOTE ON SUBSTITUTE FOR SENATE BILL NO. 11

SUPPLEMENTAL NOTE ON SUBSTITUTE FOR SENATE BILL NO. 11 Corrected SESSION OF 2007 SUPPLEMENTAL NOTE ON SUBSTITUTE FOR SENATE BILL NO. 11 As Amended by House Committee of the W hole Brief* Sub. for SB 11, as amended by the House Committee of the Whole, would

More information

Title: Gifts and Business Courtesies

Title: Gifts and Business Courtesies Title: Gifts and Business Courtesies Effective Date: 5/04; Rev. 5/07 POLICY: Employees, (referred to as associates at some affiliates) officers and members of the Boards of Directors of Iowa Health System

More information

University of Cincinnati College of Medicine

University of Cincinnati College of Medicine University of Cincinnati College of Medicine Policy Policy and Guidelines for Industry Relationships Policy and Guidelines for Industry Relationships FAQ Date Updated Page 5/14/2008 2 -- 8 NB: The Institute

More information

MEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING

MEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING MEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING Why Do I Need Training/Where Do I Fit in? Why Do I Need Training? Every year millions of dollars are improperly spent because of fraud,

More information

CME Activity Development Guide TABLE OF CONTENTS

CME Activity Development Guide TABLE OF CONTENTS TABLE OF CONTENTS Introduction...4 Mission Statement...5 Office of CME...6 Definition of CME...7 ACCME Essentials...8 Certification for Category 1 Policies and Procedures Regularly Scheduled Conference...9

More information

Charter. Regulatory and Compliance Committee

Charter. Regulatory and Compliance Committee Charter Regulatory and Compliance Committee Status The Regulatory and Compliance Committee is a committee of the Board of Directors of Pfizer Inc. ( Pfizer or the Company ). Membership The Regulatory and

More information

Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011

Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011 Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011 Definitions & Examples Why it Matters Prevention, Detection and Reporting Your

More information

Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation

Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation Leslie M. Tector Quarles & Brady LLP September 30, 2014 Objectives Which federal

More information

The following presentation was based on the

The following presentation was based on the Fraud Waste and Abuse Presentation The following presentation was based on the Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training developed by the Centers for Medicare

More information

Industry Sponsored Satellite Symposia Information and Application

Industry Sponsored Satellite Symposia Information and Application Industry Sponsored Satellite Symposia Information and Application Dear ACOOG Annual Conference Exhibitor: Thank you for your interest in planning an Industry Supported Satellite Symposium in conjunction

More information

Health Policy 201 drugs. Ellen Andrews, PhD Fall 2011

Health Policy 201 drugs. Ellen Andrews, PhD Fall 2011 Health Policy 201 drugs Ellen Andrews, PhD Fall 2011 benefits Since the mid-1990s, when researchers developed a new wave of medicines to treat HIV/AIDS, the U.S. death rate from AIDS dropped about 70 percent.

More information

GSK Code of Practice for promotion and customer interactions

GSK Code of Practice for promotion and customer interactions GSK Code of Practice for promotion and customer interactions Effective 21 July 2014 GSK Code of Practice GSK s interaction with external communities and the marketing of our products to ensure their appropriate

More information

Industry Hosted Events Space Request and Registration Form

Industry Hosted Events Space Request and Registration Form Industry Hosted Events Space Request and Registration Form In an effort to provide excellent service to The Aesthetic Meeting attendees, The Aesthetic Society is requiring all exhibiting companies register

More information

A Handbook for Planning Committees Developing Educational Programs

A Handbook for Planning Committees Developing Educational Programs A Handbook for Planning Committees Developing Educational Programs Approved October 23, 2012 Educational Program Development Cycle Step 1 Convene planning committee Step 8 Review the evaluation results

More information

HIGHMARK INC. THIRD PARTY CODE OF BUSINESS CONDUCT

HIGHMARK INC. THIRD PARTY CODE OF BUSINESS CONDUCT HIGHMARK INC. THIRD PARTY CODE OF BUSINESS CONDUCT HIGHMARK.COM TABLE OF CONTENTS Overview...1 Highmark Inc. s Obligations to Third Parties...1 Highmark Inc. s Expectations for Third Parties...3 Highmark

More information

GUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY

GUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY CMA POLICY GUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY The history of health care delivery in Canada has included interaction between physicians and the pharmaceutical and health supply industries;

More information

U.S. CORPORATE ETHICS AND COMPLIANCE POLICY

U.S. CORPORATE ETHICS AND COMPLIANCE POLICY U.S. CORPORATE ETHICS AND COMPLIANCE POLICY Table of Contents Page 1. Letter from the President & CEO 3 2. Introduction 4 3. How to Handle and Report Ethical and/or Compliance Issues 5 3.1 Violations of

More information

MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations

MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations Pri-Med Institute Marissa Seligman, PharmD mseligman@pri-medinstitute.org DISCLAIMER: For informational

More information

2012-2013 MEDICARE COMPLIANCE TRAINING EMPLOYEES & FDR S. 2012 Revised

2012-2013 MEDICARE COMPLIANCE TRAINING EMPLOYEES & FDR S. 2012 Revised 2012-2013 MEDICARE COMPLIANCE TRAINING EMPLOYEES & FDR S 2012 Revised 1 Introduction CMS Requirements As of January 1, 2011, Federal Regulations require that Medicare Advantage Organizations (MAOs) and

More information

Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies

Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies 2008 Medco Health Solutions, Inc. All rights reserved. Training Introduction In this training, you ll learn

More information

HIPAA PRIVACY FOR EMPLOYERS A Comprehensive Introduction. HIPAA Privacy Regulations-General

HIPAA PRIVACY FOR EMPLOYERS A Comprehensive Introduction. HIPAA Privacy Regulations-General HIPAA PRIVACY FOR EMPLOYERS A Comprehensive Introduction HIPAA Privacy Regulations-General The final HIPAA Privacy regulation was released on December 20, 2000 and was effective for compliance on April

More information

GUIDE TO VERMONT S PRESCRIBED PRODUCTS LAW FOR FY10 DISCLOSURES Published by the Vermont Office of the Attorney General 11/5/2009

GUIDE TO VERMONT S PRESCRIBED PRODUCTS LAW FOR FY10 DISCLOSURES Published by the Vermont Office of the Attorney General 11/5/2009 Introduction GUIDE TO VERMONT S PRESCRIBED PRODUCTS LAW FOR FY10 DISCLOSURES Published by the Vermont Office of the Attorney General 11/5/2009 Effective July 1, 2009, Vermont law bans certain gifts and

More information

Compliance and Program Integrity Melanie Bicigo, CHC, CEBS mlbicigo@uphp.com 906-225-7749

Compliance and Program Integrity Melanie Bicigo, CHC, CEBS mlbicigo@uphp.com 906-225-7749 Compliance and Program Integrity Melanie Bicigo, CHC, CEBS mlbicigo@uphp.com 906-225-7749 Define compliance and compliance program requirements Communicate Upper Peninsula Health Plan (UPHP) compliance

More information

Behavioral Healthcare, Inc. 155 Inverness Drive West Suite 201 Englewood, CO 80112

Behavioral Healthcare, Inc. 155 Inverness Drive West Suite 201 Englewood, CO 80112 1 of 6 I. Policy: It is the policy of Behavioral Healthcare, Inc. (BHI) that all employees (including management, consultants, contractors, and other agents) shall comply with all applicable Federal and

More information

Federal and State Laws Relating to False Claims and False Statements

Federal and State Laws Relating to False Claims and False Statements Federal and State Laws Relating to False Claims and False Statements The federal False Claims Act, the federal Program Fraud Civil Remedies Act, New York State's False Claims Act and certain other New

More information

Updated HIPAA Regulations What Optometrists Need to Know Now. HIPAA Overview

Updated HIPAA Regulations What Optometrists Need to Know Now. HIPAA Overview Updated HIPAA Regulations What Optometrists Need to Know Now The U.S. Department of Health & Human Services Office for Civil Rights recently released updated regulations regarding the Health Insurance

More information

A Handbook for Planning Committees Developing Educational Programs

A Handbook for Planning Committees Developing Educational Programs A Handbook for Planning Committees "This document was developed based on similar materials produced with permission by the Canadian Cardiovascular Society" Page 1 Educational Program Development Cycle

More information

FRAUD, WASTE & ABUSE. Training for First Tier, Downstream and Related Entities. Slide 1 of 24

FRAUD, WASTE & ABUSE. Training for First Tier, Downstream and Related Entities. Slide 1 of 24 FRAUD, WASTE & ABUSE Training for First Tier, Downstream and Related Entities Slide 1 of 24 Purpose of this Program On December 5, 2007, the Centers for Medicare and Medicaid Services ( CMS ) published

More information

Direct Marketing. INSU 2500 Chapter 5 Insurance Occupations. E-Commerce. Insurance Marketing and Distribution

Direct Marketing. INSU 2500 Chapter 5 Insurance Occupations. E-Commerce. Insurance Marketing and Distribution Direct Marketing INSU 2500 Chapter 5 Insurance Occupations Sept. 12 & 14 Insurance companies sell insurance directly to consumers. No middleman; no branch operation. Examples: Mail solicitations, E-commerce

More information

BlueCross BlueShield of Tennessee Senior Care Division and Volunteer State Health Plan

BlueCross BlueShield of Tennessee Senior Care Division and Volunteer State Health Plan BlueCross BlueShield of Tennessee Senior Care Division and Volunteer State Health Plan Fraud Waste and Abuse Training for Providers, First Tier, Downstream and Related Entities Overview The Centers for

More information

New Safe Harbors and Stark Exceptions for Electronic Prescribing and Electronic Health Records Arrangements

New Safe Harbors and Stark Exceptions for Electronic Prescribing and Electronic Health Records Arrangements New Safe Harbors and Stark Exceptions for Electronic Prescribing and Electronic Health Records Arrangements November 15, 2006 Steve Nash and Sara Hill, Holme Roberts & Owen LLP Agenda Introduction Background

More information

Comments on the 21 st Century Cures: Digital Health Care

Comments on the 21 st Century Cures: Digital Health Care Comments on the 21 st Century Cures: Digital Health Care July 22, 2014 The Pharmaceutical Research and Manufacturers of America (PhRMA) appreciates the opportunity to provide input to the House Energy

More information

Regulatory Compliance Training For Management. Revised 4-29-15

Regulatory Compliance Training For Management. Revised 4-29-15 Regulatory Compliance Training For Management Revised 4-29-15 Why Does Management Need Specialized Regulatory Compliance Training? Regulations impact: Contracts Grants Clinical Trials Reimbursement Failure

More information

SECTION 18 1 FRAUD, WASTE AND ABUSE

SECTION 18 1 FRAUD, WASTE AND ABUSE SECTION 18 1 FRAUD, WASTE AND ABUSE Annual FW&A Training Required for Providers and Office Staff 1 Examples of Fraud, Waste and Abuse 2 Fraud, Waste and Abuse Program Policy 3 Suspected Non-Compliance

More information

Privacy Space. Public Place. How to Protect PHI and be HIPAA Compliant

Privacy Space. Public Place. How to Protect PHI and be HIPAA Compliant Privacy Space. Public Place. How to Protect PHI and be HIPAA Compliant Event Type Live Online ACPE Expiration Date 12/11/2016 Credits 1 Contact Hour Target Audience Pharmacy Technicians Program Overview

More information

Compliance Plan False Claims Act & Whistleblower Provisions Purpose/Policy/Procedures

Compliance Plan False Claims Act & Whistleblower Provisions Purpose/Policy/Procedures CATHOLIC CHARITIES OF THE ROMAN CATHOLIC DIOCESE OF SYRACUSE, NY and TOOMEY RESIDENTIAL AND COMMUNITY SERVICES Compliance Plan False Claims Act & Whistleblower Provisions Purpose/Policy/Procedures Purpose:

More information

o DOSAGE AND ADMINISTRATION Dosage in Special Populations: The recommended initial dose is 0.5 mg BID in patients who are elderly

o DOSAGE AND ADMINISTRATION Dosage in Special Populations: The recommended initial dose is 0.5 mg BID in patients who are elderly Some critics of Janssen, including plaintiff s lawyers, have stated it is improper for Risperdal to have been used to treat elderly dementia patients. As you consider that position, we suggest you consider

More information

Second Circuit Vacates Off-Label Promotion Conviction on First Amendment Grounds in U.S. v. Caronia

Second Circuit Vacates Off-Label Promotion Conviction on First Amendment Grounds in U.S. v. Caronia December 20, 2012 Second Circuit Vacates Off-Label Promotion Conviction on First Amendment Grounds in U.S. v. Caronia For more information, contact: Edward M. Basile +1 202 626 2903 ebasile@kslaw.com Pam

More information

Health Care Compliance Association 888-580-8373 www.hcca-info.org

Health Care Compliance Association 888-580-8373 www.hcca-info.org Volume Thirteen Number Six Published Monthly Meet Danna Teicheira, System Privacy Officer at St. Luke s Health System page 16 Earn CEU Credit www.hcca-info.org/quiz see page 19 Compliant DMEPOS telemarketing:

More information

HIPAA Business Associate Contract. Definitions

HIPAA Business Associate Contract. Definitions HIPAA Business Associate Contract Definitions Terms used, but not otherwise defined, in this Agreement shall have the same meaning as those terms in the Privacy Rule. Examples of specific definitions:

More information

MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING

MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING 2 0 1 4 Introduction The Medicare and Medicaid programs are governed by statutes, regulations, and policies PacificSource must have an effective

More information

E-Commerce. INSU 2500 Chapter 5 Insurance Occupations INSURANCE OCCUPATIONS. Direct Marketing AGENT. Insurance Marketing and Distribution

E-Commerce. INSU 2500 Chapter 5 Insurance Occupations INSURANCE OCCUPATIONS. Direct Marketing AGENT. Insurance Marketing and Distribution E-Commerce INSU 2500 Chapter 5 Insurance Occupations Feb. 14, 2006 Convenience (i.e., 24-7). Cost-cutting; efficiencies. Price comparisons/shopping. Little or no human interaction. Auto and term life insurance

More information

Medicare Fraud, Waste, and Abuse Training for Healthcare Professionals 2010-2011

Medicare Fraud, Waste, and Abuse Training for Healthcare Professionals 2010-2011 Medicare Fraud, Waste, and Abuse Training for Healthcare Professionals 2010-2011 Y0067_H2816_H6169_WEB_UAMC IA 11/22/2010 Last Updated: 11/22/2010 Medicare Requirements The Centers for Medicare and Medicaid

More information

Healthcare Law Compliance Guide (commonly known as the White Guide)

Healthcare Law Compliance Guide (commonly known as the White Guide) Pfizer Inc 235 East 42nd Street New York, NY 10017 www.pfizer.com Dear Colleagues: At Pfizer, we are committed to upholding the highest standards when we interact with physicians, healthcare organizations,

More information

Policies and Procedures SECTION:

Policies and Procedures SECTION: PAGE 1 OF 5 I. PURPOSE The purpose of this Policy is to fulfill the requirements of Section 6032 of the Deficit Reduction Act of 2005 by providing to Creighton University employees and employees of contractors

More information